Imaging in drug development.
Herbst
Roy S
RS
Section of Thoracic Oncology, The University of Texas M. D. Anderson Cancer Center, USA.
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D015415:Biomarkers; D001783:Blood Flow Velocity; D003952:Diagnostic Imaging; D016503:Drug Delivery Systems; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D047569:Laser Scanning Cytometry; D008279:Magnetic Resonance Imaging / Q000379:methods; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D049268:Positron-Emission Tomography; D014463:Ultrasonography
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D015415:Biomarkers